Hypothetically, the inhibition of IL-10 or the coactivation of CD40, IL-12, IL-8, and TNF-α, could repolarize these macrophages to the M1 phenotype, where reverse tumor development has been demonstrated (57). The gene discussed is CXCL8; the disease is neoplasm.